T1	Participants 476 515	Enrolled in the study were 184 patients
T2	Participants 1155 1363	144 patients who received a third infusion, 138 responded to questions on bisphosphonate preference, and of these 138, 92% (127) preferred Z to P, because shorter infusions caused less disruption to their day
T3	Participants 1370 1403	12% of eligible patients (16/138)
T4	Participants 1481 1494	184 patients,
